NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation (NMTC) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · NMTC · as of Jun 9, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
11
12 Months
Buy/Sell ratio
0.27
Buy/Sell (by trades)
Overall sentiment
NeuroOne Medical Technologies Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
NMTC insider buying and selling by quarter
NMTC insider selling · NMTC insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · NMTC ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
NMTC executive sell shares · NMTC board member insider trading · NMTC insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 3, 2026 | Mills Jason Richard Director | Award | 41,929 | — | Form 4 |
| Apr 3, 2026 | MATHIESEN JEFFREY S Director | Award | 41,929 | — | Form 4 |
| Apr 3, 2026 | BUCKMAN PAUL Director | Award | 41,929 | — | Form 4 |
| Apr 3, 2026 | Andrle Edward Director | Award | 41,929 | — | Form 4 |
| Mar 30, 2026 | Christianson Mark Business Development Director | Sale | 15,363 | $11K | Form 4 |
| Mar 31, 2026 | Christianson Mark Business Development Director | Other | 253 | $197 | Form 4 |
| Mar 31, 2026 | Mertens Steve CTO | Other | 906 | $704 | Form 4 |
| Mar 31, 2026 | Rosa David A CEO and President · Director | Other | 2,458 | $2K | Form 4 |
| Mar 12, 2026 | Christianson Mark Business Development Director | Sale | 817 | $654 | Form 4 |
| Mar 13, 2026 | Christianson Mark Business Development Director | Sale | 100 | $80 | Form 4 |
| Mar 10, 2026 | Christianson Mark Business Development Director | Sale | 11,611 | $9K | Form 4 |
| Mar 11, 2026 | Christianson Mark Business Development Director | Sale | 2,109 | $2K | Form 4 |
| Mar 1, 2026 | Wambeke David J. Chief Business Officer | Purchase | 1,000,000 | $670K | Form 4 |
| Feb 18, 2026 | Mertens Steve CTO | Other | 7,376 | $5K | Form 4 |
| Feb 18, 2026 | Christianson Mark Business Development Director | Other | 1,812 | $1K | Form 4 |
| Feb 18, 2026 | Rosa David A CEO and President · Director | Other | 71,325 | $49K | Form 4 |
| Dec 31, 2025 | Mertens Steve CTO | Other | 906 | $687 | Form 4 |
| Dec 31, 2025 | Rosa David A CEO and President · Director | Other | 2,458 | $2K | Form 4 |
| Dec 31, 2025 | Christianson Mark Business Development Director | Other | 253 | $192 | Form 4 |
| Dec 18, 2025 | Mills Jason Richard Director | Award | 7,758 | — | Form 4 |
| Sep 30, 2025 | Mertens Steve CTO | Other | 906 | $805 | Form 4 |
| Sep 30, 2025 | Christianson Mark Business Development Director | Other | 253 | $225 | Form 4 |
| Sep 30, 2025 | Rosa David A CEO and President · Director | Other | 2,458 | $2K | Form 4 |
| Sep 5, 2025 | Christianson Mark Business Development Director | Sale | 30,000 | $22K | Form 4 |
| Jun 30, 2025 | Christianson Mark Business Development Director | Other | 253 | $172 | Form 4 |
Christianson Mark
Business Development Director
Date
Mar 30
Shares
15,363
Price
$0.74
Value
$11K
Christianson Mark
Business Development Director
Date
Mar 31
Shares
253
Price
$0.78
Value
$197
Rosa David A
CEO and President · Director
Date
Mar 31
Shares
2,458
Price
$0.78
Value
$2K
Christianson Mark
Business Development Director
Date
Mar 12
Shares
817
Price
$0.80
Value
$654
Christianson Mark
Business Development Director
Date
Mar 13
Shares
100
Price
$0.80
Value
$80
Christianson Mark
Business Development Director
Date
Mar 10
Shares
11,611
Price
$0.80
Value
$9K
Christianson Mark
Business Development Director
Date
Mar 11
Shares
2,109
Price
$0.80
Value
$2K
Wambeke David J.
Chief Business Officer
Date
Mar 1
Shares
1,000,000
Price
$0.67
Value
$670K
Christianson Mark
Business Development Director
Date
Feb 18
Shares
1,812
Price
$0.68
Value
$1K
Rosa David A
CEO and President · Director
Date
Feb 18
Shares
71,325
Price
$0.68
Value
$49K
Rosa David A
CEO and President · Director
Date
Dec 31
Shares
2,458
Price
$0.76
Value
$2K
Christianson Mark
Business Development Director
Date
Dec 31
Shares
253
Price
$0.76
Value
$192
Christianson Mark
Business Development Director
Date
Sep 30
Shares
253
Price
$0.89
Value
$225
Rosa David A
CEO and President · Director
Date
Sep 30
Shares
2,458
Price
$0.89
Value
$2K
Christianson Mark
Business Development Director
Date
Sep 5
Shares
30,000
Price
$0.74
Value
$22K
Christianson Mark
Business Development Director
Date
Jun 30
Shares
253
Price
$0.68
Value
$172
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About NMTC insider trading
NMTC insider trades
NeuroOne Medical Technologies Corporation (NMTC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Christianson Mark (Business Development Director), Mertens Steve (CTO), Rosa David A (CEO and President · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. NMTC insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For NeuroOne Medical Technologies Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
NMTC insider trading · 5 questionsThe insiders of NeuroOne Medical Technologies Corporation (NMTC) include executives and directors such as Christianson Mark (Business Development Director), Mertens Steve (CTO), Rosa David A (CEO and President · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026